📣For ESMO members: Breaking Science in #GastrointestinalCancers. David Tougeron discusses Pembrolizumab combo with XELOX and bev for pMMR/MSS mCRC and high immune infiltrate. 👉 Discover this video and more in the series on OncologyPRO now. 🔗 https://ow.ly/rGPT50SHXxz
ESMO - European Society for Medical Oncology
Gemeinnützige Organisationen
Lugano, Ticino 78.540 Follower:innen
A reference for oncology education and information
Info
Representing more than 35,000 oncology professionals from 170 countries worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE.
- Website
-
http://www.esmo.org
Externer Link zu ESMO - European Society for Medical Oncology
- Branche
- Gemeinnützige Organisationen
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Lugano, Ticino
- Art
- Nonprofit
- Gegründet
- 1975
- Spezialgebiete
- Oncology, Education & Training, CME, Cancer und Medical Oncology
Orte
-
Primär
Via Ginevra 4
Lugano, Ticino 6900, CH
-
Le Quadra
6ème étage
Nice, FR
Beschäftigte von ESMO - European Society for Medical Oncology
-
Francesca Longo
Career & Professional Development Projects Manager at ESMO - European Society for Medical Oncology
-
Federico Miliacca
ICT Solutions Manager at ESMO - European Society for Medical Oncology
-
Andrea Norsa
Head of Digital - European Society for Medical Oncology
-
Paula Franklin
Updates
-
📣 #ESMO24: All titles and authors of regular abstracts now online. Check the programme to get a glimpse of the exciting science you can look forward to and register TODAY. Secure your place today and join us in Barcelona for an inspiring and impactful congress. Benefit from advantageous fees if you register by 7 August 2024. 🗓️ Event Dates: 13 –17 September 2024 📍 Location: Barcelona, Spain and Online Why Attend? ✅Cutting-Edge Research: Explore the latest advancements in oncology across various disciplines. ✅Expert Insights: Learn from leading oncologists, researchers, and healthcare professionals. ✅Networking Opportunities: Connect with peers, potential collaborators, and industry leaders. ✅Interactive Sessions: Engage in stimulating sessions, panel discussions, and Q&A opportunities. ✅Cultural Experience: Enjoy the rich history, stunning architecture, and vibrant culture of Barcelona 🔗 https://ow.ly/z4BW50SJO3y
-
-
📣 To mark today's World Head and Neck Cancer Day, ESMO is hosting a new webinar based on the #ESMOGuidelines created with @ERN_EURACAN for the treatment of #NPC. 👉Join the global effort to improve outcomes for patients with head and neck cancers! Register with your free ESMO account #WorldHeadAndNeckCancerDay 🔗https://ow.ly/hG5950SHTsr
-
-
📣 Do not miss your chance to attend the ESMO Preceptorship on Practising Oncology. Join your international colleagues and key opinion leaders in #Perioperative strategies in various tumour settings in 📍Lugano (3-4 October) for two days of debates on state-of-the-art. ⏰ Please submit your application by 28th of July. 🔗 https://ow.ly/OV7H50SKKXM
-
-
📣 For ESMO members: Breaking Science in #GastrointestinalCancers Giovanni Randon presents Switch maintenance with ramucirumab plus paclitaxel in advanced HER2-negative gastric/GEJ cancer 👉 Discover this video and more in the series on OncologyPRO now. 🔗 https://ow.ly/fzEY50SHUCz
-
-
📢Summer alert: Sunscreens are crucial for protecting our skin from harmful UV exposure, but they can also enter waterways and harm the ecosystem. There is no perfect sunscreen that is 100% safe for the environment and provides the highest level of skin protection. However, we can take steps to balance the risks and benefits of sunscreen use. In the #OneHealth column on #ESMODailyReporter, Paweł Sobczuk discusses how we can make informed decisions to protect both our health and that of the environment. 🔗https://ow.ly/9Vc050SK3Ab
-
📣 #ESMOImmuno24: Don’t miss your chance for global recognition. Present your research to an international audience of top-tier scientists, clinicians, and industry experts. ⏰ Deadline: 1 October 2024 ✅Networking: Connect with leading researchers, potential collaborators, and industry pioneers. ✅Professional Growth: Gain visibility and enhance your profile within the scientific community. ✅Publication Opportunity: Accepted abstracts, including late-breaking abstracts, will be published online only in ESMO IOTECH. We welcome submissions on a wide range of #ImmunoOncology topics, including: #BiomarkerDevelopment Cell therapy/Immune engineering #ClinicalPractice Therapeutic development #Tumour biology and tumour microenvironment Miscellaneous 🔗 https://ow.ly/b4lE50SHT8K
-
-
📣For ESMO members: Breaking Science in #GastrointestinalCancers: Kohei Shitara talks about the Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer. 👉 Don't miss this video and others from the series on OncologyPRO. 🔗 https://ow.ly/70cr50SHUhk
-
-
📣 #ESMO4Climate: As we prepare for #ESMO24, ESMO encourages all delegates to travel in the most climate-friendly way possible and consider taking the train to Barcelona whenever possible. Our local partner is ready to assist with train bookings, ensuring your journey is both sustainable and convenient. 🚆 Find out more about the #TrainToESMO initiative and the available travel discounts. Together, we can have a positive impact and ensure a better future for everyone. 🔗 https://ow.ly/6SVl50SGUbu
-
-
📣 ESMO is in the process of globalising its Patient Advocates Working Group (PAWG) to identify the challenges and opportunities facing patients with cancer and develop a global patient strategy to contribute tangibly to the delivery of sustainable cancer care worldwide. Members of the PAWG will be required to: ✅ Represent the views of their parent organisation on the ESMO PAWG for an initial 2-year term. ✅ Attend quarterly meetings – 3 virtual and 1 in person at the ESMO Congress. ✅ Assist ESMO staff with the review, analysis and drafting of policy papers. ✅ Develop the program for the Patient Advocacy tracks at ESMO’s European and Asian congresses. ✅ Share their expertise in the development of ESMO’s Clinical Practice Guidelines and other resources. ✅ Upon request, represent ESMO at both internal and external events. ✅ Undertake additional tasks flowing from the development of the Global Patient Strategy. ⏰ Interested parties should send their 📨 application by 18:00 CET on 27th September. 👉 More information here: 🔗https://ow.ly/zNmY50SHfxY
-